Stocktoria
Medicus Pharma Ltd. MDCX
Medicus Pharma Ltd. financials (annual)
Bars are annual figures from 2023 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| R&D expense | $7.7M | $3.5M | $193,578 |
| Operating income | -$34.4M | -$11.2M | -$4.7M |
| Income tax | $0 | $0 | $0 |
| Net income | -$47.3M | -$11.2M | -$5.3M |
| EPS (diluted) | $-2.74 | $-1.16 | $-1.53 |
| Operating cash flow | -$22.8M | -$10.2M | -$4.2M |
| Cash & equivalents | $8.7M | $4.2M | $1.7M |
| Total assets | $10.1M | $5.6M | $1.9M |
| Total liabilities | $10.0M | $2.5M | $781,609 |
| Shareholders' equity | -$67,554 | $3.1M | $1.1M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.